| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033454297 |
| P356 | DOI | 10.1245/S10434-010-1399-Z |
| P953 | full work available at URL | http://www.annalssurgicaloncology.org/cgi/content/abstract/18/4/1195 |
| P698 | PubMed publication ID | 21042944 |
| P2093 | author name string | Erito Mochiki | |
| Hiroyuki Kuwano | |||
| Yoshitaka Toyomasu | |||
| Takayuki Asao | |||
| Atsushi Ogawa | |||
| Kyoichi Ogata | |||
| Tetsuro Ohno | |||
| Mitsuhiro Yanai | |||
| Ryuusuke Aihara | |||
| Hiroyuki Ando | |||
| P2860 | cites work | A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma | Q24319940 |
| Structure, chromosomal localization, and expression of 12 genes of the MAGE family | Q28238754 | ||
| The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28 | Q28274173 | ||
| Altered DNA methylation: a secondary mechanism involved in carcinogenesis | Q34504084 | ||
| Demethylation of MAGE promoters during gastric cancer progression | Q36696751 | ||
| MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer | Q36785925 | ||
| DNA methylation: a marker for carcinogen exposure and cancer risk | Q37232224 | ||
| The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. | Q37491118 | ||
| Expression of the melanoma antigen-encoding gene in human lung cancer | Q40868308 | ||
| Human esophageal carcinomas frequently express the tumor‐rejection antigens of MAGE genes | Q42678145 | ||
| Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors | Q43810956 | ||
| Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples | Q44488217 | ||
| Japanese Classification of Gastric Carcinoma - 2nd English Edition - | Q51050338 | ||
| High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. | Q53349508 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell differentiation | Q210861 |
| P304 | page(s) | 1195-1203 | |
| P577 | publication date | 2010-11-02 | |
| P1433 | published in | Annals of Surgical Oncology | Q2853069 |
| P1476 | title | Clinical significance of melanoma antigen-encoding gene-1 (MAGE-1) expression and its correlation with poor prognosis in differentiated advanced gastric cancer | |
| P478 | volume | 18 |
| Q33820811 | Association of MAGE A1-6 Expression with Lung Cancer Progression |
| Q30829189 | CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis |
| Q38434224 | Clinical significance of melanoma-associated antigen A1-6 expression in sputum of patients with squamous cell carcinoma of the larynx and hypopharynx |
| Q47157952 | Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen |
| Q58763204 | Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs |
| Q34502094 | Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma |
| Q41618310 | High expression of MAGE-A9 is associated with unfavorable survival in esophageal squamous cell carcinoma |
| Q40430454 | Human MageB2 Protein Expression Enhances E2F Transcriptional Activity, Cell Proliferation, and Resistance to Ribotoxic Stress |
| Q52800577 | Lack of XAGE-1b and NY-ESO-1 in metastatic lymph nodes may predict the potential survival of stage III melanoma patients. |
| Q38845661 | MAGE-A1-6 expression in patients with head and neck squamous cell carcinoma: impact on clinical patterns and oncologic outcomes |
| Q37700791 | Overexpression of Testes-Specific Protease 50 (TSP50) Predicts Poor Prognosis in Patients with Gastric Cancer |
| Q57280332 | PTK7 as a novel marker for favorable gastric cancer patient survival |
| Q44312375 | Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma |
| Q48526119 | Testes-specific protease 50 (TSP50) promotes invasion and metastasis by inducing EMT in gastric cancer |
Search more.